Upfront multi‐bipolar radiofrequency ablation for HCC in transplant‐eligible cirrhotic patients with salvage transplantation in case of recurrence
暂无分享,去创建一个
M. Ziol | J. Nault | F. Dondero | M. Lesurtel | G. N’kontchou | O. Sutter | V. Grando | A. Demory | Alexis Laurent | François Cauchy | L. Blaise | Olivier Soubrane | Nathalie Ganne-Carrié | Carina Boros | Pierre Nahon | François Durand | Oliver Seror
[1] B. Sensi,et al. Primary versus Salvage Liver Transplantation after Curative-Intent Resection or Radiofrequency Ablation for Hepatocellular Carcinoma: Long-Term Oncological Outcomes , 2023, Cancers.
[2] J. Zucman‐Rossi,et al. Genetics of Hepatocellular Carcinoma: From Tumor to Circulating DNA , 2023, Cancers.
[3] T. Reichman,et al. Long-term outcomes of ablation, liver resection, and liver transplant as first-line treatment for solitary HCC of 3 cm or less using an intention-to-treat analysis: A retrospective cohort study , 2022, Annals of medicine and surgery.
[4] P. Nahon,et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma developed on non‐alcoholic fatty liver disease , 2021, Liver international : official journal of the International Association for the Study of the Liver.
[5] M. Cescon,et al. The Role of Salvage Transplantation in Patients Initially Treated With Open Versus Minimally Invasive Liver Surgery: An Intention‐to‐Treat Analysis , 2020, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[6] A. Singal,et al. Addition of [18F]Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography to Cross‐Sectional Imaging Improves Staging and Alters Management in Hepatocellular Carcinoma , 2020, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[7] Oumeima Laifa,et al. Predicting Survival After Hepatocellular Carcinoma Resection Using Deep Learning on Histological Slides , 2020, Hepatology.
[8] M. Sherman,et al. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients. , 2019, Journal of hepatology.
[9] J. Fung,et al. Long-term survival comparison between primary transplant and upfront curative treatment with salvage transplant for early stage hepatocellular carcinoma. , 2019, Asian journal of surgery.
[10] P. Schirmacher,et al. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.
[11] V. Bourcier,et al. Multibipolar Radiofrequency Ablation for the Treatment of Mass-Forming and Infiltrative Hepatocellular Carcinomas > 5 cm: Long-Term Results , 2018, Liver Cancer.
[12] A. Luciani,et al. Curative salvage liver transplantation in patients with cirrhosis and hepatocellular carcinoma: An intention‐to‐treat analysis , 2018, Hepatology.
[13] G. Otto,et al. Intention‐to‐treat survival benefit of liver transplantation in patients with hepatocellular cancer , 2017, Hepatology.
[14] P. Nahon,et al. Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations. , 2017, Journal of hepatology.
[15] P. Nahon,et al. Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment-Long-term Results. , 2016, Radiology.
[16] V. Mazzaferro,et al. Early Hepatocellular Carcinoma on the Procrustean Bed of Ablation, Resection, and Transplantation , 2014, Seminars in Liver Disease.
[17] S. Imbeaud,et al. A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection. , 2013, Gastroenterology.
[18] M. Zoli,et al. Ten-Year Outcome of Radiofrequency Thermal Ablation for Hepatocellular Carcinoma: An Italian Experience , 2012, The American Journal of Gastroenterology.
[19] F. Roudot-thoraval,et al. Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria. , 2012, Gastroenterology.
[20] V. Paradis,et al. Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: An intention‐to‐treat analysis , 2012, Hepatology.
[21] P. Majno,et al. Intention‐to‐treat analysis of liver transplantation for hepatocellular carcinoma: Living versus deceased donor transplantation , 2011, Hepatology.
[22] V. Paradis,et al. 57 BENEFIT OF RESECTION OF HCC FOLLOWED BY SALVAGE TRANSPLANTATION IN CASE OF RECURRENCE: AN INTENTION-TO-TREAT ANALYSIS , 2011 .
[23] A. Luciani,et al. Liver Resection for Transplantable Hepatocellular Carcinoma: Long-Term Survival and Role of Secondary Liver Transplantation , 2009, Annals of surgery.
[24] J. Llovet,et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. , 2009, Gastroenterology.
[25] Luigi Solbiati,et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? , 2007, Hepatology.
[26] N. Demartines,et al. Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of surgery.
[27] J. Bruix,et al. Intention‐to‐treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation , 1999, Hepatology.
[28] ndrea,et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.
[29] O. Seror,et al. Comparison of no-touch multi-bipolar vs. monopolar radiofrequency ablation for small HCC. , 2017, Journal of hepatology.
[30] E. Vicaut,et al. Survival after radiofrequency ablation and salvage transplantation in patients with hepatocellular carcinoma and Child-Pugh A cirrhosis. , 2012, Journal of hepatology.
[31] P. Bossuyt,et al. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. , 2012, The Lancet. Oncology.
[32] L. Mariani,et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. , 2009, The Lancet. Oncology.
[33] G. Paumgartner,et al. European Association for the Study of the Liver , 2006 .
[34] D. Woodfield. Hepatocellular carcinoma. , 1986, The New Zealand medical journal.